HPV Clinical Trials

Find clinical trials for HPV. Search for HPV clinical trials in different cities and states across the United States.

Filter

Filter results

Results: 116

Stereotactic Boost & Short-course Radiation TherapyStereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer

Recruiting

PHASE2

Sponsor:

Centre hospitalier de l'Université de Montréal (CHUM)

Location:

London, Montreal

Code:

NCT04178174

Conditions

Head and Neck Cancer

Oropharynx Cancer

Human Papilloma Virus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

SABR boost and de-escalated chemoradiation

Standard chemoradiation

CemiplimabTrial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca

Recruiting

PHASE2

Sponsor:

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Location:

Baltimore MD

Code:

NCT04988074

Conditions

HPV-Related Squamous Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cemiplimab

AbemaciclibImmune Modulation by Abemaciclib in HNSCC. (AIM Trial)

Recruiting

PHASE2

Sponsor:

University of Arizona

Location:

Tucson AZ

Code:

NCT04169074

Conditions

HNSCC

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Abemaciclib

E7 TCR-T Cell ImmunotherapyE7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Recruiting

PHASE2

Sponsor:

Christian Hinrichs

Location:

New Brunswick NJ

Code:

NCT05686226

Conditions

Cervical Cancer

Throat Cancer

Oropharynx Cancer

Anal Cancer

Vulva Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

E7 TCR-T cells

Aldesleukin

Observational StudyAnal High-risk HPV, HSIL, and Microbiome Among Hispanic Peoples Living With HIV (PLWH)

Recruiting

Sponsor:

UCLA

Location:

San Francisco CA

Code:

NCT06651957

Conditions

Human Immunodeficiency Virus

Human Papillomavirus-Related Anal Squamous Cell Carcinoma

High-Grade Squamous Intraepithelial Lesions

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Questionnaires

STAR0602A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants with Advanced Solid Tumors

Recruiting

PHASE1

PHASE2

Sponsor:

Marengo Therapeutics, Inc.

Location:

Celebration FL, Miami FL, Bethesda MD, Boston MAshow 4 more

Code:

NCT05592626

Conditions

Advanced Solid Tumors

Genital Neoplasm, Female

Urogenital Neoplasms

Lung Neoplasm

Neoplasms by Site

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

STAR0602

Pembrolizumab & OlaparibPembrolizumab Plus Olaparib in LA-HNSCC

Recruiting

PHASE2

Sponsor:

UNC Lineberger Comprehensive Cancer Center

Location:

Indianapolis IN, Louisville KY, Chapel Hill NC, Charleston SC

Code:

NCT05366166

Conditions

Squamous Cell Carcinoma of Head and Neck

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Olaparib

Cisplatin

IMRT (intensity modulated radiation therapy)

HPV VaccineHPV Vaccine Reminders - SEARCH II Study

Recruiting

Sponsor:

Columbia University

Location:

New York NY

Code:

NCT06161831

Conditions

Human Papillomavirus Vaccination

Eligibility Criteria

Sex: Female

Age: 10 - 14

Healthy Volunteers: Not accepted

Interventions

Text Message/automated phone reminder

Surgical Resection with IMRTTransoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer

Recruiting

PHASE2

Sponsor:

Heath Skinner

Location:

Pittsburgh PA

Code:

NCT05388773

Conditions

Oropharynx Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

therapeutic conventional surgery

laboratory biomarker analysis

quality-of-life assessment

intensity-modulated radiation therapy

Cisplatin

HLA TestingA Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

Recruiting

Sponsor:

TScan Therapeutics, Inc.

Location:

Scottsdale AZ, San Diego CA, New Haven CT, Hollywood FLshow 13 more

Code:

NCT05812027

Conditions

Head and Neck Cancer

Cervical Cancer

Non Small Cell Lung Cancer

Melanoma

Ovarian Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tumor and HLA Profiling